Literature DB >> 15162542

Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China.

Jin-Hai Wang1, Jin-Yan Luo, Lei Dong, Jun Gong, Ming Tong.   

Abstract

AIM: Gastroesophageal reflux disease (GERD) is a common disorder in the Western population, but detailed population-based data in China are limited. The aim of this study was to understand the epidemiology of symptomatic gastroesophageal reflux (SGER) in adults of Xi'an, a northwestern city of China, and to explore the potential risk factors of GERD.
METHODS: Symptoms suggestive of GERD, functional dyspepsia (FD), irritable bowel syndrome (IBS), upper respiratory diseases and some potential risk factors were investigated in a face-to-face manner in a region-stratified random samples of 2789 residents aged 18-70 years in Xi'an by using a standardized questionnaire.
METHODS: With a response rate of 91.8%, the prevalence of SGER was 16.98% (95% CI, 14.2-18.92) in Xi'an adults, and no gender-related difference was observed (P<0.05). SGER was more common among subjects aged 30-70 years than in those aged 18-29 years (P<0.01). The prevalence of SGER in rural, urban and suburban subjects was 21.07%, 17.44% and 12.12%, respectively, and there was a significant difference between rural, urban and suburban regions (P<0.05). Compared with subjects without SGER, the prevalence of symptoms suggestive of FD and IBS, pneumonia, asthma, bronchitis, laryngitis, pharyngitis, chronic cough, wheeze, globus sensation, oral ulcer and snore was significantly increased in subjects with SGER (P<0.01). Heavy smoking (OR=5.76; CI, 3.70-6.67), heavy alcohol use (OR=2.85; CI, 1.67-4.49), peptic ulcer (OR=5.76; CI, 3.99-8.32), cerebral palsy (OR=3.97; CI, 1.97-8.00), abdominal operation (OR=2.69; CI, 1.75-4.13), obesity (OR=2.16; CI, 1.47-3.16), excessive food intake (OR=1.43; CI, 1.17-1.15), sweet food (OR=1.23; CI, 0.89-1.54), and consumption of coffee (OR=1.23; CI, 0.17-2.00) were independently associated with SGER. The episodes of GERD were commonly precipitated by dietary factors (66.05%), followed by body posture (26.54%), ill temper (23.72%), fatigue (22.32%) and stress (10.93%).
CONCLUSION: GERD is common in Xi'an's adult population with a mild or moderate degree. The etiology and pathogenesis of GERD are probably associated with FD, IBS, and some respiratory, laryngopharyngeal and odontostological diseases or symptoms. Some lifestyles, diseases and dietary factors are the risk factors of GERD.

Entities:  

Mesh:

Year:  2004        PMID: 15162542      PMCID: PMC4572771          DOI: 10.3748/wjg.v10.i11.1647

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease.

Authors:  Ryan C Branski; Neil Bhattacharyya; Jo Shapiro
Journal:  Laryngoscope       Date:  2002-06       Impact factor: 3.325

2.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

Authors:  V N Shirvani; R Ouatu-Lascar; B S Kaur; M B Omary; G Triadafilopoulos
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

3.  Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?

Authors:  G Holtmann; H Goebell; N J Talley
Journal:  Am J Gastroenterol       Date:  1997-06       Impact factor: 10.864

4.  Obesity correlates with gastroesophageal reflux.

Authors:  B L Fisher; A Pennathur; J L Mutnick; A G Little
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

5.  Predominant symptoms identify different subgroups in functional dyspepsia.

Authors:  V Stanghellini; C Tosetti; A Paternicò; R De Giorgio; G Barbara; B Salvioli; R Corinaldesi
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

6.  The prevalence of gastro-oesophageal reflux disease based on non-specific symptoms in institutionalized, intellectually disabled individuals.

Authors:  C J Böhmer; E C Klinkenberg-Knol; R C Niezen-de Boer; S G Meuwissen
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-02       Impact factor: 2.566

7.  Gastroesophageal reflux: the features in elderly patients.

Authors:  Xun Huang; Hui-Ming Zhu; Chuan-Zhen Deng; G Bianchi Porro; O Sangaletti; F Pace
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

8.  Risk factors associated with symptoms of gastroesophageal reflux.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

9.  Gastric acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine.

Authors:  S Cohen; G H Booth
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

10.  Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

Authors:  N J Talley; P Boyce; M Jones
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

View more
  52 in total

1.  Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area.

Authors:  Sushil Kumar; Saurabh Sharma; Tsering Norboo; Diskit Dolma; Angchuk Norboo; Tsering Stobdan; S Rohatgi; K Munot; Vineet Ahuja; Anoop Saraya
Journal:  Indian J Gastroenterol       Date:  2010-12-23

Review 2.  Is alcohol consumption associated with gastroesophageal reflux disease?

Authors:  Shao-hua Chen; Jie-wei Wang; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-06       Impact factor: 3.066

3.  Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms.

Authors:  Chao Yan; Wei-Tao Liang; Zhong-Gao Wang; Zhi-Wei Hu; Ji-Min Wu; Chao Zhang; Mei-Ping Chen
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

4.  The Role of Helicobacter pylori in Upper Respiratory System Infections: Is it More Than Colonization?

Authors:  Mucahit Yemisen; Bilgul Mete; Asiye Kanbay; Ilker Inanc Balkan; Resat Ozaras
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 5.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

6.  The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Seyed Mehrbod Atshani; Sepideh Chagharvand; Fatemeh Souti
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

7.  Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period.

Authors:  Yu Jing Fan; Xin Song; Ji Lin Li; Xue Min Li; Bin Liu; Ran Wang; Zong Min Fan; Li Dong Wang
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

8.  The effect of Roux-en-Y gastric bypass on gastroesophageal reflux disease in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Yi-Chia Lee; Ming-Shiang Wu; Chi-Yang Chang; Ching-Tai Lee; Chih-Kun Huang; Hsin-Chih Kuo; Jaw-Town Lin
Journal:  Obes Surg       Date:  2008-10-15       Impact factor: 4.129

9.  Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.

Authors:  Mandeep Singh; Jaehoon Lee; Neil Gupta; Srinivas Gaddam; Bryan K Smith; Sachin B Wani; Debra K Sullivan; Amit Rastogi; Ajay Bansal; Joseph E Donnelly; Prateek Sharma
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

10.  A 12-month follow-up study on the preventive effect of oral lansoprazole on acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Wei Xiong; Quan-San Zhang; Wei Zhao; Wei Ding; Jin-Ming Liu; Yun-Feng Zhao
Journal:  Int J Exp Pathol       Date:  2016-05-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.